The GEO Group Inc
GEO
CoreCivic, Inc.
CXW
UnitedHealth
UNH
Eli Lilly and Co
LLY
Tractor Supply
TSCO
(FY)Oct 31, 2024 | (Q4)Oct 31, 2024 | (Q2)Apr 30, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | (Q2)Apr 30, 2023 | (FY)Oct 31, 2022 | (Q4)Oct 31, 2022 | (Q2)Apr 30, 2022 | (FY)Oct 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash cash equivalents and federal funds sold | 80.62%311.67K | 80.62%311.67K | 43.64%1.49M | 67.34%172.56K | 67.34%172.56K | -67.97%1.04M | --103.12K | --103.12K | --3.24M | ---- |
-Cash and cash equivalents | 80.62%311.67K | 80.62%311.67K | 43.64%1.49M | 67.34%172.56K | 67.34%172.56K | -67.97%1.04M | --103.12K | --103.12K | --3.24M | ---- |
Receivables | -5.75%2.07M | -5.75%2.07M | -48.78%3.71M | -62.62%2.19M | -62.62%2.19M | -34.89%7.25M | -74.01%5.86M | --5.86M | -79.41%11.13M | 63.26%22.56M |
-Available for sale securities | ---- | ---- | --4.04M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Deferred costs | 19.94%263.64K | 19.94%263.64K | --243.01K | --219.81K | --219.81K | ---- | ---- | ---- | ---- | ---- |
Total assets | 14.06%2.82B | 14.06%2.82B | 5.55%2.79B | 1.67%2.47B | 1.67%2.47B | -3.24%2.64B | -24.08%2.43B | --2.43B | -11.66%2.73B | 29.97%3.21B |
Liabilities | ||||||||||
Payables | -77.02%4.47M | -77.02%4.47M | 245.94%12.72M | 117.08%19.44M | 117.08%19.44M | -75.91%3.68M | -42.45%8.96M | --8.96M | -52.86%15.26M | 30.75%15.56M |
-Accounts payable | ---- | ---- | --9.68M | --16.14M | --16.14M | ---- | ---- | ---- | -57.60%11.03M | ---- |
-Total tax payable | 188.87%1.27M | 188.87%1.27M | -45.08%514.83K | -18.17%439.76K | -18.17%439.76K | 157.56%937.45K | --537.43K | --537.43K | --363.98K | ---- |
-Other payable | 11.58%3.2M | 11.58%3.2M | -8.09%2.52M | -65.97%2.87M | -65.97%2.87M | -29.13%2.74M | -45.90%8.42M | --8.42M | -39.23%3.86M | 617.22%15.56M |
Derivative product liabilities | -18.13%3.11M | -18.13%3.11M | -40.08%6.15M | -87.84%3.79M | -87.84%3.79M | 103.60%10.26M | -10.62%31.21M | --31.21M | -74.67%5.04M | 606.77%34.91M |
Other liabilities | 19.94%263.64K | 19.94%263.64K | ---- | --219.81K | --219.81K | ---- | ---- | ---- | ---- | ---- |
Total liabilities | -66.23%8.16M | -66.23%8.16M | 30.57%19.42M | -40.73%24.18M | -40.73%24.18M | -28.53%14.88M | -20.59%40.79M | --40.79M | -60.86%20.81M | 195.27%51.37M |
Shareholders'equity | ||||||||||
Share capital | -0.11%3.06M | -0.11%3.06M | 0.00%3.06M | 0.00%3.06M | 0.00%3.06M | 0.24%3.06M | 0.59%3.06M | --3.06M | 0.89%3.06M | 0.54%3.04M |
-common stock | -0.11%3.06M | -0.11%3.06M | 0.00%3.06M | 0.00%3.06M | 0.00%3.06M | 0.24%3.06M | 0.59%3.06M | --3.06M | 0.89%3.06M | 0.54%3.04M |
Paid-in capital | -4.53%1.74B | -4.53%1.74B | -7.55%1.82B | -7.55%1.82B | -7.55%1.82B | 0.12%1.97B | 0.66%1.97B | --1.97B | -1.60%1.97B | -2.13%1.95B |
Retained earnings | 71.01%1.07B | 71.01%1.07B | 44.21%947.99M | 48.70%628.44M | 48.70%628.44M | -11.44%657.37M | -64.69%422.63M | --422.63M | -28.51%742.29M | 166.45%1.2B |
Total stockholders'equity | 14.85%2.81B | 14.85%2.81B | 5.40%2.77B | 2.39%2.45B | 2.39%2.45B | -3.05%2.63B | -24.14%2.39B | --2.39B | -10.79%2.71B | 28.79%3.15B |
Total equity | 14.85%2.81B | 14.85%2.81B | 5.40%2.77B | 2.39%2.45B | 2.39%2.45B | -3.05%2.63B | -24.14%2.39B | --2.39B | -10.79%2.71B | 28.79%3.15B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Audit Opinions | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- | Unqualified Opinion |